高心血管风险-话题@MedSci

#高心血管风险#

15篇内容 | 613人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1663111, encodeId=7fd21663111ee, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Diabetologia：利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能，但会增加出血风险, objectType=article, longId=216896, objectId=0a1721689639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a1721689639, replyNumber=0, likeNumber=38, createdTime=2021-10-31, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a1721689639, moduleTitle=Diabetologia：利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能，但会增加出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a1721689639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663112, encodeId=bfb3166311288, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Eur Heart J：高甘油三酯血症和高心血管风险受试者降脂治疗, objectType=article, longId=294008, objectId=56e52940080f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56e52940080f, replyNumber=0, likeNumber=37, createdTime=2022-08-08, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56e52940080f, moduleTitle=Eur Heart J：高甘油三酯血症和高心血管风险受试者降脂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56e52940080f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663110, encodeId=264c1663110f6, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Eur J Nucl Med Mol Imaging：心肌灌注显像可预测高心血管风险的无症状糖尿病患者的预后, objectType=article, longId=210330, objectId=d6e52103309d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e52103309d, replyNumber=0, likeNumber=43, createdTime=2021-07-17, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e52103309d, moduleTitle=Eur J Nucl Med Mol Imaging：心肌灌注显像可预测高心血管风险的无症状糖尿病患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e52103309d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663109, encodeId=a0b2166310900, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Int J Cardiol：各种颈动脉超声参数对高和极高心血管风险患者的预后价值, objectType=article, longId=168736, objectId=c036168e36dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c036168e36dd, replyNumber=0, likeNumber=44, createdTime=2019-11-03, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c036168e36dd, moduleTitle=Int J Cardiol：各种颈动脉超声参数对高和极高心血管风险患者的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c036168e36dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663108, encodeId=1a9d166310881, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Ann Intern Med：中国人高心血管风险的特点, objectType=article, longId=161593, objectId=d016161593ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d016161593ca, replyNumber=0, likeNumber=35, createdTime=2019-08-13, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d016161593ca, moduleTitle=Ann Intern Med：中国人高心血管风险的特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d016161593ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663106, encodeId=2edd166310637, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=2018 专家共识：高尿酸血症和高心血管风险患者的诊断和治疗, objectType=article, longId=153302, objectId=2e19153302ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e19153302ae, replyNumber=0, likeNumber=26, createdTime=2019-09-03, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e19153302ae, moduleTitle=2018 专家共识：高尿酸血症和高心血管风险患者的诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e19153302ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663105, encodeId=9d1a1663105f5, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=JAHA：艾塞那肽对高心血管风险2型糖尿病患者的疗效研究, objectType=article, longId=149505, objectId=f36714950581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f36714950581, replyNumber=0, likeNumber=34, createdTime=2018-10-28, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f36714950581, moduleTitle=JAHA：艾塞那肽对高心血管风险2型糖尿病患者的疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f36714950581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663107, encodeId=1073166310ec0, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Chest：接受CPAP的高心血管风险OSA患者多模式远程监测效果, objectType=article, longId=154296, objectId=d3a1154296fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a1154296fd, replyNumber=0, likeNumber=32, createdTime=2019-01-19, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a1154296fd, moduleTitle=Chest：接受CPAP的高心血管风险OSA患者多模式远程监测效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a1154296fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663104, encodeId=fd6e166310420, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Circulation：对于糖尿病患者和无糖尿病的高心血管风险的患者，他汀类药物中添加依泽替米贝可增强治疗效果, objectType=article, longId=135097, objectId=129713509e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=129713509e03, replyNumber=0, likeNumber=26, createdTime=2018-09-14, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=129713509e03, moduleTitle=Circulation：对于糖尿病患者和无糖尿病的高心血管风险的患者，他汀类药物中添加依泽替米贝可增强治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=129713509e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663103, encodeId=d9ba1663103fd, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Eur Heart J：高心血管风险的糖尿病患者血压和心血管结局分析！, objectType=article, longId=128653, objectId=b423128653d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b423128653d0, replyNumber=0, likeNumber=33, createdTime=2018-02-15, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b423128653d0, moduleTitle=Eur Heart J：高心血管风险的糖尿病患者血压和心血管结局分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b423128653d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663101, encodeId=1b641663101a0, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Heart：高心血管风险的患者是选择ACEIs还是ARBs？, objectType=article, longId=91658, objectId=06e191658b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06e191658b6, replyNumber=0, likeNumber=28, createdTime=2017-09-13, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06e191658b6, moduleTitle=Heart：高心血管风险的患者是选择ACEIs还是ARBs？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06e191658b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663102, encodeId=12aa1663102fe, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Heart:高心血管风险的COPD患者：吸入性治疗影响心血管结局吗？, objectType=article, longId=114502, objectId=bffb11450261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bffb11450261, replyNumber=0, likeNumber=24, createdTime=2017-12-24, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bffb11450261, moduleTitle=Heart:高心血管风险的COPD患者：吸入性治疗影响心血管结局吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bffb11450261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663100, encodeId=107716631008c, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=Diabetes Care：ω-3脂肪酸对于高心血管风险成人预后没有作用, objectType=article, longId=69032, objectId=2633690322f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2633690322f, replyNumber=0, likeNumber=33, createdTime=2016-07-28, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2633690322f, moduleTitle=Diabetes Care：ω-3脂肪酸对于高心血管风险成人预后没有作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2633690322f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663099, encodeId=85641663099c9, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=BMJ：3种炎症性疾病提高心血管风险, objectType=article, longId=42286, objectId=0ae542286c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ae542286c9, replyNumber=0, likeNumber=33, createdTime=2015-04-13, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ae542286c9, moduleTitle=BMJ：3种炎症性疾病提高心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ae542286c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1663098, encodeId=28a11663098e8, content=<a href='/topic/show?id=d0d7102384ee' target=_blank style='color:#2F92EE;'>#高心血管风险#</a>, objectTitle=DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险, objectType=article, longId=40984, objectId=53c6409848a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53c6409848a, replyNumber=0, likeNumber=40, createdTime=2015-01-07, rootId=0, userName=ms1065684921169360, userId=8bea25523459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53c6409848a, moduleTitle=DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53c6409848a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高心血管风险

2020-05-29

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Diabetologia：利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能，但会增加出血风险

2021-10-31

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Eur Heart J：高甘油三酯血症和高心血管风险受试者降脂治疗

2022-08-08

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Eur J Nucl Med Mol Imaging：心肌灌注显像可预测高心血管风险的无症状糖尿病患者的预后

2021-07-17

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Int J Cardiol：各种颈动脉超声参数对高和极高心血管风险患者的预后价值

2019-11-03

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Ann Intern Med：中国人高心血管风险的特点

2019-08-13

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

2018 专家共识：高尿酸血症和高心血管风险患者的诊断和治疗

2019-09-03

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

JAHA：艾塞那肽对高心血管风险2型糖尿病患者的疗效研究

2018-10-28

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Chest：接受CPAP的高心血管风险OSA患者多模式远程监测效果

2019-01-19

智慧医人 (审核中...)

前往app查看评论内容

#高心血管风险#

Circulation：对于糖尿病患者和无糖尿病的高心血管风险的患者，他汀类药物中添加依泽替米贝可增强治疗效果

2018-09-14

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Eur Heart J：高心血管风险的糖尿病患者血压和心血管结局分析！

2018-02-15

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Heart：高心血管风险的患者是选择ACEIs还是ARBs？

2017-09-13

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Heart:高心血管风险的COPD患者：吸入性治疗影响心血管结局吗？

2017-12-24

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

Diabetes Care：ω-3脂肪酸对于高心血管风险成人预后没有作用

2016-07-28

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

BMJ：3种炎症性疾病提高心血管风险

2015-04-13

ms1065684921169360 (审核中...)

前往app查看评论内容

#高心血管风险#

DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险

2015-01-07

科室
- - 订阅+
  - 更多科室
工具
服务